Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Gender issues
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Health consequences
Gender issues — Social contexts/determinants
Gender issues — User perspectives
Youth — Gender Issues
Wednesday, 23 October
10:50
Understanding and improving health and social outcomes
10:50
to
12:20
Networking zone 3 (N3)
Sanna Rönkä
Poster guided tour
Progress in alcohol research and responses - EUFAS poster session 1
10:50
to
12:20
Guided poster tours room
Colin Drummond
12:20
Measuring drug use to monitor trends in different populations - ISSDP poster session 1
12:20
to
13:20
Guided poster tours room
Nicola Singleton
13:20
Risk behaviours in context
13:20
to
14:50
Networking zone 2 (N2)
Anja Busse
16:50
Issues, challenges and future perspectives
Gender and drugs in Europe
16:50
to
18:20
Networking zone 1 (N1)
Alessandra Liquori
Linda Montanari
Thursday, 24 October
10:50
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
Understanding behaviours, risks and harms
10:50
to
12:20
Networking zone 3 (N3)
Xavier Majó
Alcohol perspectives and prevention - EUFAS poster session 2
10:50
to
12:20
Guided poster tours room
Linn Gjersing
12:20
Making better use of existing data through standardisation, methods and analysis - ISSDP poster session 2
12:20
to
13:20
Guided poster tours room
Rosalie Pacula
13:20
Treatment adherence
13:20
to
14:50
Insights zone 4 (I4)
Marta Torrens Melich
The Reitox network poster session
13:20
to
14:50
Guided poster tours room
Nadine Berndt
18:30
Nightlife, festivals and other recreational settings
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Friday, 25 October
10:45
Findings from a feasibility trial and formative evaluation in England
The development and implementation of the ADVANCE intervention to reduce intimate partner violence perpetration by men in substance use treatment
10:45
to
12:15
Central square 3 (C3)
Gail Gilchrist
Treatment — improving standards and outcomes
10:45
to
12:15
Networking zone 3 (N3)
Gerhard Bühringer
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:50
Poster
Exposure to alcohol and/or cadmium changes status of bioelements in rat tests
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
'Drink to forget' – a case report
10:50
to
12:20
Guided poster tours room
Mariana Lázaro
Poster
Screening for alcohol-related cognitive impairments – a case study
10:50
to
12:20
Guided poster tours room
Luisa Gil
Poster
Neuroprotective role of argan oil against alcohol use disorders in adolescent wistar rat
10:50
to
12:20
Guided poster tours room
Hicham El Mostafi
Poster
Cadmium and/or ethanol increase oxidative stress in liver of the exposed rats
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
Screening and brief interventions for reducing alcohol consumption in a department of firefighters in the central region of Portugal
10:50
to
12:20
Guided poster tours room
Teresa Barroso
Poster
Court proceedings and actions taken by a probation officer in work with people addicted to alcohol.
10:50
to
12:20
Guided poster tours room
Ewelina Silecka-Marek
Poster
Elderly wellbeing and alcohol - a tricky cocktail
10:50
to
12:20
Guided poster tours room
Jakob Emiliussen
11:00
Short communication
Portuguese gender-sensitive harm reduction services: bridging the gap
11:00
to
11:10
Networking zone 3 (N3)
11:10
Short communication
A change in the prescribing practice of prebagalin that has had a direct negative effect on drug-induced deaths in Ireland
11:10
to
11:20
Networking zone 3 (N3)
Ena Lynn
11:30
Short communication
Performance enhancing drugs. Results from a Belgian survey on PED use among workers
11:30
to
11:40
Networking zone 3 (N3)
Marie-Claire Lambrechts
11:40
Short communication
Drug and alcohol treatment: how much does it cost in Europe?
11:40
to
11:50
Networking zone 3 (N3)
Claudia Costa Storti
11:50
Short communication
Young people's exposure to gambling advertisements: a mixed methods study in Australia.
11:50
to
12:00
Networking zone 3 (N3)
Hannah Pitt
12:00
Short communication
Street Work Nursing as an innovative strategy in the care for dually diagnosed individuals: reflections on a pilot study
12:00
to
12:10
Networking zone 3 (N3)
Ilse Goethals
12:10
Short communication
Dissuasion, the effectiveness of the intervention and good practices
12:10
to
12:20
Networking zone 3 (N3)
Américo Gegaloto
12:20
Poster
Illegal drug trends in Taiwan, 2009-2018
12:20
to
13:20
Guided poster tours room
Kai-Hsiang Kang
Poster
Gender convergence in alcohol consumption: outcomes from general population survey on drugs, Portugal 2001-2016/17
12:20
to
13:20
Guided poster tours room
Clara Vital
Poster
Monitoring recreational drug use in Switzerland
12:20
to
13:20
Guided poster tours room
Dominique Schori
Poster
Prevalence and patterns of drug use indicator (‘GPS’)
12:20
to
13:20
Guided poster tours room
Federica Mathis
Poster
European web survey on drugs: patterns of use
12:20
to
13:20
Guided poster tours room
João Matias
13:30
Oral presentation
Substance Use Sex Index (SUSI): towards a new behaviour change assessment tool
13:30
to
13:45
Networking zone 2 (N2)
Nadine Ezard
13:45
Oral presentation
Chemsex experiences: pleasures, harms and care
13:45
to
14:00
Networking zone 2 (N2)
Maitena Milhet
14:00
Oral presentation
The counselors’ perspective on the use of methamphetamine in a sexual context among men who have sex with men
14:00
to
14:15
Networking zone 2 (N2)
Valérie Aubut
14:15
Oral presentation
Faster, higher, stronger? Results from a Belgian survey on PED use among gym-goers
14:15
to
14:30
Networking zone 2 (N2)
Bertrand Fincoeur
16:50
Oral presentation
Drug use, drug related problems and responses among women in Europe: latest European data
16:50
to
18:20
Networking zone 1 (N1)
Eleni Kalamara
Oral presentation
Female-oriented medicosocial responses in French drug treatment facilities. Results from the Ad-femina survey
16:50
to
18:20
Networking zone 1 (N1)
Carine Mutatayi
Oral presentation
Violence and substance use among women
16:50
to
18:20
Networking zone 1 (N1)
Florence Mabileau
Ourania Botsi
Panellists
16:50
to
18:20
Networking zone 1 (N1)
Franca Beccaria
Brendan Hughes
Analia Torres
Sharon Arpa
Linda Lombi
Thursday, 24 October
10:50
Poster
Alcohol addiction as a social problem in Ukraine: history of research
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
The alcohol consumption in the modern Ukraine: tendences and perspecties.
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
Alcohol and drugs in contemporary school pupils on the verge of adolescence: the Polish experience
10:50
to
12:20
Guided poster tours room
Katarzyna Pawelek
Poster
The role of alcohol in fatal fires in Ireland
10:50
to
12:20
Guided poster tours room
Anne Doyle
Poster
Do parents want to change alcohol legislations to protect their children?
10:50
to
12:20
Guided poster tours room
Marta Zin-Sedek
Poster
Social and context determinants of drinking during working time – Portuguese GPS findings 2017
10:50
to
12:20
Guided poster tours room
Cláudia Urbano
Poster
Sub-groups of tobacco and alcohol co-use trajectories from ages 21 to 32: the Amsterdam growth and health longitudinal study
10:50
to
12:20
Guided poster tours room
Sterling McPherson
Poster
Effects of an alcohol prevention program at sport stadiums: a 2-year follow-up study using pseudopatrons and breath alcohol concentration levels
10:50
to
12:20
Guided poster tours room
Tobias Elgan
Poster
Implementing and evaluating alcohol and drug prevention methods at youth health clinics
10:50
to
12:20
Guided poster tours room
Pia Kvillemo
Poster
Accessing alcohol drinking influence in workplace – What is the panorama and current innovations in Portugal?
10:50
to
12:20
Guided poster tours room
Duarte Vital Brito
11:00
Short communication
Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance
11:00
to
11:10
Networking zone 4 (N4)
Patricia Gómez
Short communication
Neuropsychological functioning, psychopathology, and parenting behaviours in the context of substance use disorders: which are the implications for treatment?
11:00
to
11:10
Networking zone 3 (N3)
Alessio Porreca
11:10
Short communication
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
11:10
to
11:20
Networking zone 4 (N4)
Lies Gremeaux
Short communication
Childhood adversity within adolescent friendship groups: Implications for subsequent substance use disorders
11:10
to
11:20
Networking zone 3 (N3)
Lauren Bishop
11:20
Short communication
From chronology to processes: combining biographical interview with episodic analysis in a life story
11:20
to
11:30
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
Cause-specific hospitalisation and death in a cohort of people who use heroin and crack cocaine in London, England: the importance of non-communicable diseases, skin infections, head injuries and dental caries
11:20
to
11:40
Networking zone 3 (N3)
Dan Lewer
11:30
Short communication
Coding multiple drug use in ICD-10 and ICD-11
11:30
to
11:40
Networking zone 4 (N4)
Espen Walderhaug
Short communication
Yearning to be better than good –Lithuanian students of medicine use of cognitive enhancers among
11:30
to
11:40
Networking zone 3 (N3)
Aiste Lengvenyte
11:40
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
New issues regarding drug-related deaths: combined suicide
11:40
to
11:50
Networking zone 3 (N3)
Mateja Jandl
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Daniela Filipa Ferreira
11:50
Short communication
The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia
11:50
to
12:00
Networking zone 4 (N4)
Short communication
Women and HIV in prison setting: data from the Italian ROSE network
11:50
to
12:00
Networking zone 3 (N3)
12:00
Short communication
Non-national clients in Belgian drug treatment: different profile characteristics compared to Belgian clients
12:00
to
12:10
Networking zone 3 (N3)
Charlotte De Kock
Short communication
Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review
12:00
to
12:10
Networking zone 4 (N4)
12:10
Short communication
Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland
12:10
to
12:20
Networking zone 4 (N4)
Michelle Foley
12:20
Poster
Epidemiology of illicit drug use and policy evaluation: the heroin epidemics example
12:20
to
13:20
Guided poster tours room
Carla Rossi
Poster
Scalable family therapy training materials for adolescents with substance use disorder (UNFT)
12:20
to
13:20
Guided poster tours room
Anja Busse
Poster
Community Reinforcement and Family Training (CRAFT) - a cluster randomised controlled trial comparing individual, group and self-help interventions.
12:20
to
13:20
Guided poster tours room
Randi Bilberg
Poster
Can environmental prevention effectively complement efforts in responding to the psychoactive substance abuse among forensic patients?
12:20
to
13:20
Guided poster tours room
Poster
Development of the UNODC-WHO quality assurance mechanism and standards for the treatment of drug use disorders
12:20
to
13:20
Guided poster tours room
Annette Dale-Perera
Anja Busse
Poster
Preliminary methodological analysis on the lexicometric assessment of laws and drugs policies and evaluation of social outcomes
12:20
to
13:20
Guided poster tours room
Carla Rossi
Poster
Development of the UNODC-WHO quality assurance mechanism and standards for the treatment of drug use disorders
12:20
to
13:20
Guided poster tours room
Wataru Kashino
13:20
Poster
Trends on the Dutch drug market identified by DIMS in 2018
13:20
to
14:50
Guided poster tours room
Laura Smit-Rigter
Poster
Gendered sources of drug supply for recreational drug users in the European Web Survey on Drugs
13:20
to
14:50
Guided poster tours room
Michael Vuolo
Poster
Trends in primary substance mentioned by patients entering treatment for illicit substance use in Belgium between 2012 and 2018
13:20
to
14:50
Guided poster tours room
Antoine Jérôme
Poster
Criminal reactions and reduction of crime and drug use in drug-using offenders
13:20
to
14:50
Guided poster tours room
Olga Souza Cruz
Poster
Fatal traffic accidents in connection to driving under the influence of psychoactive substances
13:20
to
14:50
Guided poster tours room
Ada Hocevar Grom
Poster
HIV infection in drug users in harm reduction structures
13:20
to
14:50
Guided poster tours room
Isabel Ponte
Poster
Drug-related deaths and mortality in Europe
13:20
to
14:50
Guided poster tours room
Federica Mathis
Poster
Demand for drug treatment in Europe: the Treatment Demand indicator (TDI)
13:20
to
14:50
Guided poster tours room
Linda Montanari
Poster
Non-medical prescription drug use among Estonian adults
13:20
to
14:50
Guided poster tours room
Sigrid Vorobjov
Poster
Monitoring drug-related infectious diseases in Europe
13:20
to
14:50
Guided poster tours room
Thomas Seyler
Poster
Estimating the number of people who inject drugs (PWID) in Europe
13:20
to
14:50
Guided poster tours room
Thomas Seyler
13:30
Oral presentation
Use of contingency management (positive reinforcement with financial incentives) to encourage abstinence from heroin (PRAISE): a UK cluster randomised trial
13:30
to
13:45
Insights zone 4 (I4)
Nicola Metrebian
Timothy Weaver
13:45
Oral presentation
Opioid maintenance treatment (OMT) – not life-long for all women? 10 years follow-up after pregnancy - how many stop OMT and what are the results?
13:45
to
14:00
Insights zone 4 (I4)
Gabrielle Welle-Strand
14:00
Oral presentation
A look at the dark side of addiction treatment: a profile of those who drop out
14:00
to
14:15
Insights zone 4 (I4)
João Augusto
14:15
Oral presentation
Methadone serum concentrations and influencing factors: a naturalistic observational study
14:15
to
14:30
Insights zone 4 (I4)
Fatemeh Chalabianloo
14:30
Oral presentation
Is methadone treatment more effective for lower socio-economic status opiate users? Results from a case crossover study in Lazio
14:30
to
14:45
Insights zone 4 (I4)
Antonella Camposeragna
18:40
Short communication
Recommendations for NPS-targeted initiatives in Belgium
18:40
to
18:50
Networking zone 3 (N3)
Anton van Dijck
18:50
Short communication
Predicting the onset of ketamine use among frequent nightlife attendees
18:50
to
19:00
Networking zone 3 (N3)
Charlotte van Miltenburg
19:00
Short communication
Why a zero tolerance drug policy for festivals is not working (well)
19:00
to
19:10
Networking zone 3 (N3)
Jochen Schrooten
19:10
Short communication
Towards gender-sensitive responses in the drugs field: Intersections between sexual violence, drug use in nightlife environments
19:10
to
19:20
Networking zone 3 (N3)
Cristiana Vale Pires
19:20
Short communication
Setting up a HPLC in a 7-day psychedelic music festival: drug checking moving forward
19:20
to
19:30
Networking zone 3 (N3)
Daniel Martins
Friday, 25 October
10:45
Oral presentation
The role of substance use in intimate partner abuse perpetration: rationale forthe ADVANCE programme of research
10:45
to
12:15
Central square 3 (C3)
Gail Gilchrist
Oral presentation
The dynamics of intimate partner abuse and drug and alcohol dependency: results from qualitative dyad interviews with male perpetrators of intimate partner abuse perpetration in substance use treatment and their current or ex female partners
10:45
to
12:15
Central square 3 (C3)
Juliet Henderson
Oral presentation
Development of an integrated intervention to reduce intimate partner abuse perpetration by men in substance use treatment: the ADVANCE intervention
10:45
to
12:15
Central square 3 (C3)
Gail Gilchrist
Oral presentation
Assessing the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment
10:45
to
12:15
Central square 3 (C3)
Gemma Halliwell
10:55
Short communication
Single-gender groups for women suffering from opioid use fisorder: theory and treatment
10:55
to
11:05
Networking zone 3 (N3)
Efrat Fridma
11:05
Short communication
Systematic monitoring and feedback on data results as supportive tools for substance use disorder individuals
11:05
to
11:15
Networking zone 3 (N3)
Thomas Solgård Svendsen
11:15
Short communication
Patient-centered care for addictions treatment: findings from a scoping review
11:15
to
11:25
Networking zone 3 (N3)
Kirsten Marchand
11:25
Short communication
OST futures: integrating the user’s experience into person-centred care
11:25
to
11:35
Networking zone 3 (N3)
Karen Black
11:35
Short communication
Telephone delivered incentives for encouraging adherence to supervised methadone (TIES): development and feasibility study
11:35
to
11:45
Networking zone 3 (N3)
Nicola Metrebian
11:45
Short communication
Benzodiazepine use in an opioide maintenance programme: risks and clinical outcomes
11:45
to
11:55
Networking zone 3 (N3)
Catarina Oliveira
11:55
Short communication
Telephone-delivered contingency management to promote behaviour change in addiction treatment.
11:55
to
12:05
Networking zone 3 (N3)
Carol-Ann Getty
12:05
Short communication
Measuring personality problems in patients with substance use disorders
12:05
to
12:15
Networking zone 3 (N3)
Espen Ajo Arnevik